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Background. Depression is a clinically relevant dimension, associated with both positive and negative symptoms, in
patients with schizophrenia. However, in siblings it is unknown whether depression is associated with subclinical
positive and negative symptoms.
Method. Depressive symptoms and their association with positive and negative symptoms were examined in 813
healthy siblings of patients with a non-aﬀective psychotic disorder, 822 patients and 527 healthy controls. Depre-
ssive episodes meeting DSM-IV-TR criteria (lifetime) and depressed mood (lifetime) were assessed with the
Comprehensive Assessment of Symptoms and History (CASH) in all three groups. In the patient group, the severity
of positive and negative psychosis symptoms was assessed with the CASH. In the siblings and healthy controls, the
severity of subclinical psychosis symptoms was assessed with the Community Assessment of Psychic Experiences
(CAPE).
Results. Patients reported more lifetime depressed mood and more depressive episodes than both siblings and
controls. Siblings had a higher chance of meeting lifetime depressive episodes than the controls ; no signiﬁcant
diﬀerences in depressed mood were found between siblings and controls. In all three groups the number and
duration of depressive symptoms were associated with (sub)clinical negative symptoms. In the patients and siblings
the number of depressive symptoms was furthermore associated with (sub)clinical positive symptoms. Finally,
lifetime depressed mood showed familial clustering but this clustering was absent for lifetime depressive episodes.
Conclusions. These ﬁndings suggest that a co-occurring genetic vulnerability for both depressive and psychotic
symptomatology exists on a clinical and a subclinical level.
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Introduction
Depression and positive symptom dimensions in
psychosis are considered to be separate but inter-
related dimensions of psychotic disorder (Krabbendam
et al. 2004 ; van Os & Kapur, 2009) and are closely
related on all levels of the psychosis continuum
(Wigman et al. 2011). Clinically, this is reﬂected by
diagnoses such as schizo-aﬀective or mood disorders
with psychotic features, in which depressive and psy-
chotic symptoms co-occur. Depression is a commonly
reported symptom in the prodromal phase of psy-
chotic illness (Ha¨fner et al. 2005a ; Iyer et al. 2008) and
has been shown to be associated with a transition to
psychosis in ultra-high-risk samples (Yung et al. 1998,
2003, 2004). In addition, in general population sam-
ples, subclinical psychotic symptoms and depression
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are associated in both adolescents (Yung et al. 2006 ;
Armando et al. 2010 ; Mackie et al. 2011 ; Wigman
et al. 2011) and adults samples (Krabbendam et al.
2004). Furthermore, the presence of depressive symp-
toms in combination with hallucinatory experiences
in the general population increases the risk for a
later diagnosis of clinical psychosis (Krabbendam et al.
2005).
Depression is a clinically relevant dimension in
patients with schizophrenia with a prevalence range
of 6–75% (average of 25%) during the course of the
illness (Sands & Harrow, 1999; Peralta & Cuesta, 2001 ;
Siris & Bench, 2003 ; Ha¨fner et al. 2005b ; van Os, 2009).
In the fully developed schizophrenia syndrome, de-
pression has been associated with outcome (Ha¨fner
et al. 1999 ; Sands & Harrow, 1999; Conley et al. 2007),
higher relapse rates (Birchwood et al. 1993) and in-
creased risk of suicide (Siris, 2001 ; Lindenmayer &
Khan, 2006). A greater insight into the relationship
between psychosis and depression can be obtained by
measuring depressive symptoms and their associ-
ations with (subclinical) psychotic symptoms in sib-
lings at genetic risk of psychosis. Siblings of patients
with schizophrenia are at increased risk for psychosis,
yet do not suﬀer from the consequences of having
a chronic and disabling disorder or treatment. In
addition, a higher prevalence of subclinical expression
of psychotic vulnerability is found in siblings (Kendler
et al. 1995 ; Fanous et al. 2001 ; Araja¨rvi et al. 2006 ; Smith
et al. 2008). However, data on the prevalence of de-
pression among siblings (including twins) are scarce.
The majority of studies reported to date have used
small numbers and their results are contradictory. Lee
et al. (2008) reported that relatives of patients with
schizophrenia experienced more diﬃculties recover-
ing from unpleasant moods compared to healthy
controls. Chang et al. (2002) and Mortensen et al. (2010)
found a higher risk for depression among siblings.
Argyropoulos et al. (2008) found that co-twins of
schizophrenia probrands are more likely to be diag-
nosed with anxiety and depression disorders than
control twins. However, other studies have not dem-
onstrated a higher depression rate among siblings
(Araja¨rvi et al. 2006) and twins of schizophrenia
patients (Lyons et al. 2000) compared to healthy con-
trols. We are not aware of any investigations of the
associations between depressive symptomatology
and (sub)clinical psychotic symptoms in siblings of
patients with non-aﬀective psychotic disorders.
In the present study we report on the presence of,
and relationship between, depressive symptoms and
(sub)clinical positive and negative symptoms in a
large cohort of non-psychotic siblings, their psychotic
probands and healthy controls. The data were ob-
tained in the Genetic Risk and Outcome in Psychosis
(GROUP) project. Our study focused on three ques-
tions :
(1) Is the lifetime presence of depressed mood or life-
time depressive episodes according to DSM-IV
more prevalent in patients with a non-aﬀective
psychotic disorder, and also in their siblings, in
comparison with healthy controls?
(2) Are the severity and duration of depressive epi-
sodes associated with (sub)clinical levels of posi-
tive and negative symptoms in all three groups?
(3) Is there a familial clustering of lifetime presence of
depressed mood or lifetime depressive episodes
according to DSM-IV?
Method
Participants
The study sample consisted of patients with a diag-
nosis of non-aﬀective psychotic disorder, their sib-
lings, and controls from the general population in the
context of the Dutch national GROUP project (Korver
et al. 2012). Patients from selected geographical areas
in The Netherlands and Belgium were identiﬁed by
representative clinicians whose caseload was screened
for inclusion criteria. Subsequently, a group of pa-
tients presenting consecutively at these services either
as out-patients or in-patients were recruited for the
study. First-degree relatives were sampled through
participating patients. Control subjects were recruited
through random mailings and advertisements in local
newspapers. Written informed consent conforming to
the guidelines approved by the local ethics committee
was obtained from all subjects. We note that no parti-
cipants from the Groningen site were included here
because the Groningen site used the Schedules for
Clinical Assessment for Neuropsychiatry (SCAN) in-
stead of the Comprehensive Assessment of Symptoms
and History (CASH; Andreasen et al. 1992 ; Korver
et al. 2012).
The inclusion criteria for the GROUP study were:
ﬂuency in Dutch; age in the range 16 to 55 years and,
additionally for the patients, a DSM-IV diagnosis of
non-aﬀective psychotic disorder, assessed by clinical
interview with the CASH, and ﬁrst contact with men-
tal health facilities within the past 10 years. At least
one sibling of each patient was required to take part in
the study. The sibling non-patient status was deﬁned
as the absence of any lifetime psychotic disorder by
CASH interview. Participants in the control group
lacked a personal psychotic disorder (CASH inter-
view) and in addition did not have a ﬁrst-degree
family member with the Family Interview for Genetic
Studies (FIGS), with themselves as informant (NIMH,
748 R. M. C. Klaassen et al.
1992). It should be noted that some controls were re-
lated. This was controlled for by using multilevel
analyses.
Measures
The sections on aﬀective and psychotic disorders
of CASH (Andreasen et al. 1992) were used to conﬁrm
(a) the presence of a diagnosis of non-aﬀective psy-
chosis in patients ; (b) the absence of such a diagnosis
in their relatives ; and (c) the absence of a lifetime
diagnosis of any psychotic disorder or any current
aﬀective disorder in the healthy controls. Furthermore,
the presence of lifetime depressed mood for a mini-
mum of 2 consecutive weeks and the lifetime presence
of clinical depression according to DSM-IV-TR criteria
were derived from the CASH interview. Both de-
pression measures (depressed mood and depressive
episodes) were dichotomous (0=absent/not meeting
criteria, 1=present/meeting criteria). The severity of
depression was characterized by the duration of the
longest depressive episode lifetime and the number
of depressive symptoms during the longest lifetime
depressive episode. Both the duration and the number
of symptoms were considered as continuous variables,
where the duration ranged from 0 to 997 days and the
number of symptoms ranged from 0 to 8. In addition,
positive and negative psychotic symptoms in the
patient group were derived from the CASH. The
weighted mean of a global evaluation of severity of
lifetime delusions and lifetime hallucinations con-
stituted the Positive Clinical Symptom Scale, a con-
tinuous variable ranging from 0 to 5 (0=none,
1=doubtful, 2=mild, 3=moderate, 4=considerable,
and 5=severe). The weighted mean of a global evalu-
ation of severity of lifetime apathy and asociality
constituted the Negative Clinical Symptom Scale,
a continuous variable ranging from 0 to 5 (0=none,
1=doubtful, 2=mild, 3=moderate, 4=considerable,
and 5=severe).
The Community Assessment of Psychic Experi-
ences (CAPE; Stefanis et al. 2002 ; Konings et al. 2006)
is a 42-item self-report measurement of psychotic
experiences in the general population. The CAPE
assesses the frequency on a scale of 0 to 3 (from
‘never ’ to ‘almost always’) of lifetime subclinical
psychotic experiences, and the distress associated with
these symptoms also on a scale of 0 to 3 (from ‘no
distress ’ to ‘much distress ’). The weighted mean of
the positive subclinical symptom frequency items
constituted the Positive Subclinical Symptom Scale
and the weighted mean of the negative subclinical
symptom frequency items constituted the Negative
Subclinical Symptom Scale for the sibling and control
groups.
Statistical analysis
First, we investigated the association between group
(controls, siblings and patients) and depression.
Multilevel logistic regression models were used
with the categorical variable group (0=controls,
1=siblings, 2=patients) as the independent variable
and the two dichotomous measures of depression
(depressed mood and depressive episodes) as depen-
dent variables. Multilevel analyses were used because
the patients and siblings, and also some of the con-
trols, were related, thus invalidating the assumption of
independence of observations and requiring con-
servative adjustment of standard errors for hierarchi-
cal clustering within families. Data were analyzed
using the XTGEE routine in Stata 11.0 (StataCorp, 2009).
All analyses were corrected a priori for a possible con-
founding eﬀect of age and sex.
In a second analysis, the association between de-
pression and (sub)clinical psychotic symptoms in the
three groups was tested separately using multilevel
regression models (again using the XTREG routine in
Stata 11.0). The two depression severity variables were
the dependent variables in all three groups. The inde-
pendent variables in the patient group were the two
clinical psychosis symptom dimensions (positive and
negative symptoms) of the CASH, and for the sibling
and control groups the two subclinical symptom
dimensions of the CAPE (positive and negative
symptoms) were used. All independent variables were
ﬁrst put in the regression model(s) separately, and at a
second stage jointly, to assess the independence of
associations. All analyses were corrected a priori for
age and sex.
Lastly, the familial clustering of depression was
assessed using logistic regression models with the
two CASH depression variables (depressed mood and
depressive episodes) in the patient serving as inde-
pendent variables, and with the same two CASH de-
pression variables in their sibling(s) as dependent
variables.
We thus performed a total of nine tests ; as we tested
research questions based on a priori assumptions,
we chose not to correct for multiple comparisons. The
level of signiﬁcance is therefore p=0.05. However,
to allow for a conservative interpretation of the pre-
sented data, we point out that the Bonferroni (n=9)
corrected level of signiﬁcance would be 0.006.
Results
Sample characteristics
The ﬁrst and the third analyses were performed on a
total of 822 patients, 813 of their siblings and 527 con-
trol participants. However, as the data on the variables
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used in the second analyses were not available for all
participants, only 607 patients, 684 siblings and 493
control participants were included in the second
analyses. The sociodemographic and clinical charac-
teristics of the three groups are presented in Table 1.
The depression variables are displayed in Table 2 and
the psychosis (sub)clinical symptoms variables in
Table 3.
The association between psychosis vulnerability
and depression
Multilevel logistic regression analyses revealed an as-
sociation between group and depressed mood
(x2=344.4, p<0.0001). The patients reported more de-
pressed mood compared to the controls [odds ratio
(OR) 7.8, 95% conﬁdence interval (CI) 5.96–10.14,
p<0.0001] and the siblings (x2=275.8, p<0.0001). No
signiﬁcant diﬀerence in depressed mood was found
between siblings and controls (OR 1.22, 95% CI 0.95–
1.57, p<0.116). Both the patients and the siblings had a
signiﬁcantly increased risk of depressive episodes
compared to the control participants (patients com-
pared to controls : OR 8.9, 95% CI 6.81–11.67,
p<0.0001 ; siblings had borderline signiﬁcantly in-
creased risk compared to controls : OR 1.28, 95% CI
1.00–1.65, p=0.050). Furthermore, the patients ex-
hibited a signiﬁcantly increased risk of depressive
episodes compared to the siblings (x2=363.3,
p<0.0001).
Depression severity and its association with
(sub)clinical psychosis symptom dimensions
Multilevel regression analyses revealed that the dur-
ation of the longest depressive episode in the patient
group was associated signiﬁcantly with positive clini-
cal psychosis symptoms (b=11.22, 95% CI 1.49–20.94,
p<0.024) and negative clinical psychosis symptoms
(b=16.08, 95% CI 7.48–24.67, p<0.0001). However, on
introducing both independent variables into a single
regression model, it was found that the negative
clinical psychosis symptoms remained associated with
the duration of the longest depressive episode
(b=14.35, 95% CI 5.27–23.43, p<0.002), whereas the
positive clinical psychosis symptoms were not
(b=6.00, 95% CI –4.22 to 16.22, p<0.250). Slightly
diﬀerent results were obtained when considering the
number of depressive symptoms during the longest
depressive episode. Both positive (b=0.47, 95% CI
0.33–0.61, p<0.0001) and negative clinical psychosis
symptoms (b=0.55, 95% CI 0.43–0.67, p<0.0001) were
Table 1. Sociodemographic and clinical sample characteristics
Patients
(n=822)
Siblings
(n=813)
Controls
(n=527)
Age (years)
Mean (S.D.) 28 (8.1) 28 (8.6) 29 (10.6)
Range 15–61 14–60 15–56
Proportion of men (%) 77 45 45
Primary DSM-IV diagnosis (lifetime), n (%)
Schizophrenia 555 (68) – –
Schizo-aﬀective disorder 108 (13) – –
Schizophreniform disorder 29 (4) – –
Psychotic disorder NOS 82 (10) – –
Other non-aﬀective psychotic disorders 48 (5) – –
Mood disorders (in full remission), n (%) – 129 (16) 55 (10)
Meeting DSM criteria for current depressive episode, n (%) 92 (12.4) 13 (1.6) 1 (0.2)
No psychopathology, n (%) – 684 (84) 472 (90)
Antipsychotics, n (%) – –
Not currently using 99 (13)
Currently using 643 (85)
Unknown 14 (2)
Antidepressants, n (%) – –
Not currently using 609 (74)
Currently using 213 (26)
Mood stabilizers, n (%) – –
Not currently using 782 (95)
Currently using 40 (5)
S.D., Standard deviation ; NOS, not otherwise speciﬁed.
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signiﬁcantly associated with the number of symptoms
in the patient group. The same conclusion was reached
when both independent variables were entered into a
single model.
The results for the sibling group were similar to
those of the patients. The duration of the longest de-
pressive episodewas signiﬁcantly associatedwith both
positive (b=87.32, 95%CI 45.71–128.93, p<0.0001) and
negative subclinical symptoms (b=67.09, 95% CI
45.21–88.96, p<0.0001). When both independent vari-
ables were entered into a single model, only the nega-
tive subclinical symptoms retained a signiﬁcant
association (negative symptoms: b=58.94, 95% CI
33.21–84.66, p<0.0001 ; positive symptoms: b=28.98,
95% CI –19.29 to 77.25, p<0.239). The number of
depressive symptoms was signiﬁcant in the model
of positive (b=3.73, 95% CI 2.79–4.67, p<0.0001)
and negative subclinical symptoms (b=2.84, 95% CI
2.37–3.31, p<0.0001) and both symptoms remained
signiﬁcant when entered together in one model.
The results for the control group diﬀered from those
of the siblings and the patients. In the control group,
the duration of the longest depressive episode was
signiﬁcant in the model of negative subclinical symp-
toms (b=47.13, 95% CI 15.00–79.25, p<0.004) but not
in the model of positive subclinical symptoms
(b=–0.30, 95% CI –58.55 to 57.94, p<0.992). The
number of depressive symptoms was signiﬁcant in the
model of positive (b=2.17, 95% CI 1.04–3.30,
p<0.0001) and negative subclinical symptoms
(b=2.08, 95% CI 1.47–2.68, p<0.0001). When both
were entered into a single model, only the negative
symptoms remained signiﬁcant (negative : b=1.89,
95% CI 1.22–2.55, p<0.0001; positive : b=0.82, 95% CI
–0.36 to 2.01, p<0.174).
In this way we identiﬁed an association between
depression and negative (sub)clinical symptoms in all
three groups. In addition, we found an association
between the number of depressive symptoms and
positive (sub)clinical psychotic symptoms but only in
the patients and the siblings.
Familial clustering of depression in families at risk
for psychosis
Multilevel logistic regression analysis revealed that
depressed mood in patients was signiﬁcantly asso-
ciated with depressed mood in their sibling(s) (OR
1.54, 95% CI 1.14–2.08, p<0.005). Depressive episodes
did not show familial clustering (OR 1.22, 95% CI
0.92–1.62, p<0.177).
Discussion
In this study we investigated the presence of, and
relationship between, depressive symptoms andT
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(sub)clinical psychotic symptoms in a cohort of pa-
tients with a psychotic disorder, their siblings, and
healthy controls. We found that patients reported
more depressed mood than controls and siblings,
whereas the siblings did not diﬀer from the controls.
Both patients and siblings exhibited a signiﬁcantly in-
creased risk of depressive episodes compared to the
controls. The duration of the longest depressive epi-
sode was found to be associated with negative but not
positive clinical psychosis symptoms in patients.
However, the number of depressive symptoms was
associated with both positive and negative clinical
psychosis symptoms. Similar results were found for
the siblings whereas in the controls only negative
subclinical psychosis was associated with the duration
of the depressive episode and the number of depress-
ive symptoms. Finally, we found evidence for familial
clustering at the level of depressed mood but not for
depressive episodes.
The ﬁndings of a higher rate of depression in sib-
lings compared to the controls are in line with
Argyropoulos et al. (2008). Nonetheless, they are at
odds with a study of siblings showing similar rates of
depression in siblings compared to controls (Araja¨rvi
et al. 2006). The higher average age of the participants
in the latter study may explain the discrepancy as the
majority of the non-psychotic siblings had already ex-
ceeded the age-related risk window for developing a
psychosis. We are not aware of earlier studies of the
association between depression and negative and
positive psychotic symptoms in siblings. Our ﬁndings
are in line with other results in populations with psy-
chotic disorder (Norman & Malla, 1991 ; Messias et al.
2001 ; Freeman & Garety, 2003 ; Drake et al. 2004).
However, as far as the healthy controls are concerned,
our results show only a partial correspondence
with other studies. Earlier studies in the general
population revealed an association between depress-
ive, negative and positive symptoms (Stefanis et al.
2002 ; Krabbendam et al. 2004, 2005), contrasting with
our ﬁnding of an association with negative symp-
tomatology only. We note that whereas a weighted
mean of all subclinical symptoms present in the CAPE
was used in the study reported here, the former stu-
dies used a diﬀerent methodology : only one positive
symptom would identify positive psychotic symp-
toms.
The results in our study suggest that the duration of
depression is only associated with the negative psy-
chosis domain in patients and siblings whereas the
number of depressive symptoms is associated with
both negative and positive psychosis symptoms.
These observations are diﬃcult to explain in a
straightforward way. They may be understood in the
light of the diﬀerent temporal dynamics of positiveT
ab
le
3.
S
co
re
s
on
C
A
S
H
(p
at
ie
n
ts
)
an
d
C
A
P
E
(s
ib
li
n
gs
an
d
co
n
tr
ol
s)
(s
u
b)
cl
in
ic
al
ps
yc
ho
si
s
sy
m
pt
om
va
ri
ab
le
s
A
n
al
y
si
s
2
P
at
ie
n
ts
R
el
at
iv
es
C
o
n
tr
o
ls
T
o
ta
l
(n
=
60
7)
M
al
e
(n
=
45
5
)
F
em
al
e
(n
=
15
2)
T
o
ta
l
(n
=
68
4)
M
al
e
(n
=
30
9
)
F
em
al
e
(n
=
37
5
)
T
o
ta
l
(n
=
49
3)
M
al
e
(n
=
22
3)
F
em
al
e
(n
=
27
0)
P
o
si
ti
v
e
cl
in
ic
al
p
sy
ch
o
si
s
sy
m
p
to
m
s
(r
an
g
e
0–
5)
3.
3
(1
.3
1)
3.
2
(1
.3
3)
3.
5
(1
.2
5)
–
–
–
–
–
–
N
eg
at
iv
e
cl
in
ic
al
p
sy
ch
o
si
s
sy
m
p
to
m
s
(r
an
g
e
0–
5)
2.
3
(1
.4
6)
2.
3
(1
.4
5)
2.
4
(1
.5
1)
–
–
–
–
–
–
P
o
si
ti
v
e
su
b
cl
in
ic
al
p
sy
ch
o
si
s
sy
m
p
to
m
s
(r
an
g
e
0–
3)
–
–
–
0.
20
(0
.2
0)
0.
19
(0
.1
8)
0.
21
(0
.2
1)
0.
18
(0
.1
8)
0.
18
(0
.1
6)
0.
18
(0
.1
9)
N
eg
at
iv
e
su
b
cl
in
ic
al
p
sy
ch
o
si
s
sy
m
p
to
m
s
(r
an
g
e
0–
3)
–
–
–
0.
54
(0
.3
7)
0.
53
(0
.3
4)
0.
55
(0
.4
0)
0.
46
(0
.3
1)
0.
44
(0
.2
9)
0.
48
(0
.3
2)
C
A
S
H
,
C
o
m
p
re
h
en
si
v
e
A
ss
es
sm
en
t
o
f
S
y
m
p
to
m
s
an
d
H
is
to
ry
;
C
A
P
E
,
C
o
m
m
u
n
it
y
A
ss
es
sm
en
t
P
sy
ch
ic
E
x
p
er
ie
n
ce
s.
V
al
u
es
g
iv
en
as
m
ea
n
(s
ta
n
d
ar
d
d
ev
ia
ti
o
n
).
752 R. M. C. Klaassen et al.
and negative psychosis. Clinically, positive symptoms
tend to vary over time, as do depressive symptoms,
whereas negative symptoms present themselves more
continuously, in a trait-like fashion. As negative
symptoms and depressive symptoms also show over-
lap (Siris, 2000), negative symptoms may be found
to be associated with the duration of depression.
However, the co-occurrence of these symptom di-
mensions may also be explained by the phenomenon
that raters are liable to rate conceptually similar
phenomena (i.e. ‘blunted aﬀect ’ as observed in nega-
tive symptoms versus ‘depressed mood’ as seen in
depression) in the same way. This obviously also
relates to the important issue of whether depressive
phenomena and (negative) psychotic phenomena are
truly separate concepts.
The results of our study suggest that depressive
symptoms are not simply a manifestation of the co-
morbidity of schizophrenia or part of the risk phase of
a psychosis but are inherently related to, in particular,
negative (sub)clinical symptoms. This is in line
with the suggestion that psychosis consists of multiple
domains [positive, negative, cognitive and aﬀective
symptoms (van Os & Kapur, 2009)]. These domains ﬁt
in a continuous (subclinical) model in which correlated
psychopathology dimensions (as seen in patients) are
also apparent in risk groups and general population
groups, only to a lesser extent (van Os et al. 2000, 2009 ;
Myin-Germeys & van Os, 2007). Our ﬁndings under-
score the presence of an inter-related depressivemood:
a (sub)clinical negative psychosis continuum. It has
been suggested that subclinical psychotic experiences
and depression are interwoven phenomena that co-
occur (Wigman et al. 2011). This previous ﬁnding is in
accordance with suggestions that levels of depression
mirror levels of subclinical psychotic experiences in the
general population (Yung et al. 2009 ; Wigman et al.
2011). Our present study supports these ﬁndings
but extends them by demonstrating that depressive
phenomena are speciﬁcally related to the negative
symptom domain. The overlap between negative and
depressive symptomatology might play a role in this.
This study has shown an existing shared vulner-
ability in families with schizophrenia for both de-
pressed mood (one of the major symptoms in a
depression) and positive and negative (sub)clinical
symptoms. This might indicate a familial vulnerability
in families with schizophrenia for both depression and
psychosis. The found associations between negative,
positive and depressive symptoms in siblings (on a
subclinical level) and in patients (on a clinical level)
also indicate an overlap between the two concepts,
depression and psychosis ; there seems to be a shared
risk that is also expressed at a subclinical level.
In siblings, subclinical psychotic experiences and
depressive symptoms may be an expression of inter-
related aspects of the same underlying factor also seen
in patients.
From a clinical point of view our ﬁndings are rel-
evant ; ﬁrst, to underscore the increased risk of a de-
pressed mood and a depressive episode for patients
suﬀering from a psychosis. Determining the temporal
appearance, duration and severity of depressive
symptoms is necessary for diagnosis and treatment
planning. A study by Yung et al. (2007) showed an
association between a reduction in depressive symp-
toms and a reduction in psychotic-like experiences.
Treating depression may include pharmacological and
psychosocial intervention. Because depressive symp-
toms may herald psychotic relapse, patients with de-
pressive symptoms should be monitored carefully.
Second, our results suggest that some of the healthy
siblings (those with more depressive symptoms) are
more at risk for psychosis then other siblings, and they
have three risk factors : age, genetic liability and de-
pressive symptoms (Hanssen et al. 2005 ; Johnstone
et al. 2005 ; Owens et al. 2005 ; Yung et al. 2007).
Our results should be interpreted in the light of the
following limitations. Our data are cross-sectional and
therefore do not provide evidence regarding of the
causal role of depressive symptoms on psychosis or
vice versa. Another potential limitation is the diﬃculty
in diﬀerentiating between negative and depressive
symptoms, causing a risk for overlap. In addition, be-
cause of the age of our group, some of the unaﬀected
siblings are at risk of developing psychosis.
We also need to consider several potential limita-
tions of the GROUP study in general. The ﬁrst is a
selection bias ; participants willing to participate in a
demanding study protocol may be diﬀerent from
participants in other less demanding studies, or from
subjects refusing to participate in research. Controls
and siblings could have a current depressive episode;
however, this may have reduced the chance of
participation in a study. Another selection bias is the
exclusion of patients without brothers or sisters.
Second, diﬀerences between relatives and healthy
controls may be diﬃcult to detect because not all sib-
lings of a speciﬁc patient are included, and siblings
with more subclinical symptoms may have been more
reluctant to participate in the GROUP study. Third,
inter-rater reliability remains a vulnerability in large
multisite studies. Within the GROUP project the inter-
rater reliability of the most important diagnostic
instruments was assessed. The inter-rater reliability of
the diagnostic classiﬁcation according to DSM-IV as
measured by the CASH was satisfactory, based on
assessing the concordance between the CASH diag-
nosis and the diagnosis assessed by the treating clin-
ician. A randomly selected comparison of 65 subjects
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with a psychotic disorder revealed a diﬀerence in
diagnosis in only one case. However, the speciﬁc inter-
rater reliability of negative and depressive symptoms
was not assessed, and this is a limitation. The inter-
rater reliability of the CAPE is not an issue, as this is
a self-report questionnaire. Fourth, in this study
we did not have the data on relevant medication for
the siblings and controls. As these may inﬂuence the
severity and the course of the symptoms, this should
be regarded as a limitation.
In conclusion, we have shown siblings and patients
to be more at risk of a depressive episode and their
depressive symptoms are associated with positive and
negative (sub)clinical psychotic symptoms. These
ﬁndings suggest that a co-occurring genetic vulner-
ability for both depressive and positive and negative
psychotic symptomatology exists on a clinical and also
on a subclinical level. Clinically, the question of the
eﬃcacy of treatment of depressive symptoms in sib-
lings for reducing (sub)clinical psychotic symptoms
and risk of transition to overt psychosis merits further
study. Finally, to investigate the relationship between
depressive symptoms and subclinical psychotic
symptoms in siblings over time, longitudinal data are
required.
APPENDIX. GROUP investigators
R. Kahn, D. Linszen, J. van Os, D. Wiersma,
R. Bruggeman, W. Cahn, L. de Haan, L. Krabbendam
and I. Myin-Germeys.
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